Showing results (1891-1900 of 3,794) with videos related to
Sort By:
Pageof 380
Oncoimmunology|July 30, 2013
Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapyYuting Ma, Takahiro Yamazaki, Heng Yang, et al.Oncoimmunology|July 30, 2013
Autoantibodies targeting tumor-associated antigens in metastatic cancer: Sialylated IgGs as candidate anti-inflammatory antibodiesMartin Oaks, Samuel Taylor, James ShafferOncoimmunology|July 30, 2013
HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patientsHans-Henning Schmidt, Yingzi Ge, Felix J Hartmann, et al.Oncoimmunology|June 14, 2013
Identification of human inflammatory dendritic cellsElodie Segura, Sebastian AmigorenaOncoimmunology|June 14, 2013
The two faces of regulatory T cells in cancerNichole R Blatner, Fotini Gounari, Khashayarsha KhazaieOncoimmunology|June 14, 2013
EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodiesStefanie Derer, Stefan Lohse, Thomas ValeriusOncoimmunology|June 14, 2013
Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cellsJean-François Fonteneau, Jean-Baptiste Guillerme, Frédéric Tangy, et al.Oncoimmunology|June 14, 2013
The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinomaSumit Agarwal, Shikha Saini, Deepak Parashar, et al.Oncoimmunology|June 14, 2013
Functional OCT4-specific CD4+ and CD8+ T cells in healthy controls and ovarian cancer patientsJiabo Di, Leon F A G Massuger, Tjitske Duiveman-de Boer, et al.Oncoimmunology|November 22, 2012
Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in miceMariana Malvicini, Laura Alaniz, Juan Bayo, et al.Pageof 380